SEC Form 4 · accession 0000313143-15-000009
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Concannon
Officer — President & CEO · Director
Period of report
Feb 2, 2015
Accepted (ET)
Feb 3, 2015 · 12:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 2, 2015 | M | 4,765 | $27.275 | A | 151,805 | D | |
| Common StockF1 | Feb 2, 2015 | S | 4,765 | $39.1459 | D | 147,040 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1,F2 | $27.275 | Feb 2, 2015 | M | 4,765 | D | Oct 22, 2009 | Oct 22, 2015 | Common Stock | 4,765 | 38,116 | D |
Explanation of responses
- F1Pursuant to a 10b5-1 Plan.
- F2Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.